Dr. Richard Miron
Dr. Richard Miron is currently lead educator and researcher at Advanced PRF Education and an Adjunct Visiting Faculty in the Department of Periodontology in Bern, Switzerland, where he completed his PhD studies in 2009.
He has published over 350 peer-reviewed articles and lectures internationally on many topics relating to growth factors, bone biomaterials, and guided bone regeneration.
For the past 5 years, Dr. Miron has been recognized by Dentistry Today as one of the top 100 CE providers in the country and the youngest to ever make the list. He is also the top-ranked researcher on Platelet-Rich Fibrin (PRF) therapy according to Expertscape independent review.
He has recently received many international awards in dentistry and is widely considered one of the top contributors to implant dentistry, having won the ITI Andre Schroeder Prize, the IADR Young Investigator of the Year in the field of Implant Dentistry, as well as the IADR Socransky Research Award in the field of Periodontology (2020).
Dr. Miron has written 8 textbooks widely distributed in regenerative dentistry, including his best-seller in 2019 titled Next Generation Biomaterials for Bone and Periodontal Regeneration and Understanding Platelet Rich Fibrin in 2021.
Main Podium Lecture
PRF and Exosomes: A Perfect Marriage in Regenerative Medicine
Platelet-rich fibrin (PRF) has been utilized in regenerative medicine and dentistry for nearly 3 decades due to its ability to accelerate both hard and soft tissue regeneration. Today, implant dentists rely on PRF to improve soft tissue healing around grafted/implant sites and to enhance the handling of bone grafting particles. It is worth noting that PRF was FDA-approved in the early 2010s, and it took over a decade for most clinicians to adopt the technology in their practices. Many improvements to the technology have been pioneered within our research and clinical affiliates, providing clinicians with the most effective means possible to produce proper platelet concentrates within their facilities.
Exosomes are the smallest subset of extracellular signaling vesicles secreted by most cells, with a diameter range of 30–150nm. Their use has gained momentum recently due to their potential as therapeutic options. In simple terms, PRF produces roughly 500 publications per year, while exosome research is generating over 5,000 publications annually. This number is expected to dramatically increase as novel therapeutic strategies continue to be investigated.
This lecture will focus first on understanding exosomes, including their cellular origin, biogenesis, function, and characterization. It will then cover their therapeutic potential, with a strong focus on dental applications, as well as the combination of exosomes and PRF in regenerative medicine.
Highlights:
- Provide an overview of the top 20 improvements in PRF therapy over the past decade to maximize clinicians' use of the technology.
- Provide a general understanding of exosomes and their massive potential to help dentists performing regenerative protocols in implant dentistry and periodontology.
- Highlight the use of exosomes and PRF in combination approaches in regenerative medicine.
Hands-on Workshop 1 (Wednesday, October 2, 2024 | 8:00am - 12:00pm)
Hands-on Workshop 2 (Wednesday, October 2, 2024 | 1:30pm - 5:30pm)
